Synthesis and Investigation of Antimicrobial, Antioxidant, Enzymatic Inhibitory, and Antiproliferative Activities of Ruthenium (II) Complexes Bearing Benzimidazole-Based N-Heterocyclic Carbene (NHC) Ligands

References

• Runbin Wang, Ming Wei, Xuerong Wang, Yushou Chen, Yanshi Xiong, Jianxin Cheng, Yanhui Tan, Xiangwen Liao, and Jintao Wang, “Synthesis of Ruthenium Polypyridine Complexes with Benzyloxyl Groups and Their Antibacterial Activities against Staphylococcus aureus,” Journal of Inorganic Biochemistry 236 (2022): 111954. doi: 10.1016/j.jinorgbio.2022.111954.
   PubMed Web of Science ®Google Scholar
• Charlestine Soh, Mohan Rao Kollipara, Venkanna Banothu, Danny F. Diengdoh, Werner Kaminsky, and E. K. Rymmai, “Synthesis and Molecular Structure of Arene Ruthenium(II) Complexes Containing Benzhydrazone Derivative Ligands with Antibacterial and Antioxidant Properties,” Journal of Molecular Structure 1269 (2022): 133775. doi: 10.1016/j.molstruc.2022.133775.
   Web of Science ®Google Scholar
• Liqiang Wang, Lianghong Liu, Xuerong Wang, Yanhui Tan, Xuemin Duan, Chunyan Zhang, Jianxin Cheng, Yanshi Xiong, Guijuan Jiang, Jintao Wang, et al, “Ruthenium(II) Complexes Targeting Membrane as Biofilm Disruptors and Resistance Breakers in Staphylococcus aureus Bacteria,” European Journal of Medicinal Chemistry 238 (2022): 114485.
   PubMed Web of Science ®Google Scholar
• K. Günther, and G. Weber, Analytiker-Taschenbuch. (Berlin, Heidelberg, New York: Springer, 1999).
   Google Scholar
• Wolfgang A. Herrmann, Martina Elison, Jakob Fischer, Christian Köcher, and Georg R. J. Artus, “Metal Complexes of N-Heterocyclic Carbenes-A New Structural Principle for Catalysts in Homogeneous Catalysis,” Angewandte Chemie International Edition in English 34, no. 21 (1995): 2371–4. doi: 10.1002/anie.199523711
   Web of Science ®Google Scholar
• E. Peris, J. Mata, J. A. Loch, and R. H. Crabtree, “A Pd Complex of a Tridentate Pincer CNC Bis-Carbene Ligand as a Robust Homogenous Heck catalystElectronic Supplementary Information (ESI) Available: Synthesis Details and NMR Data,” Chemical Communications 2, no. 2 (2001): 201–2. doi: 10.1039/B008038L
   Google Scholar
• J. Izquierdo, G. E. Hutson, D. T. Cohen, and K. A. Scheidt, “A Continuum of Progress: applications of N-Hetereocyclic Carbene Catalysis in Total Synthesis,” Angewandte Chemie (International ed. in English) 51, no. 47 (2012): 11686–98. doi: 10.1002/anie.201203704
   PubMed Web of Science ®Google Scholar
• D. T. Cohen, and K. A. Scheidt, “Cooperative Lewis Acid/N-Heterocyclic Carbene Catalysis,” Chemical Science 3, no. 1 (2012): 53–7. doi: 10.1039/C1SC00621E
   PubMed Web of Science ®Google Scholar
• H. D. Velazquez, and F. Verpoort, “N-Heterocyclic Carbene Transition Metal Complexes for Catalysis in Aqueous Media,” Chemical Society Reviews 41, no. 21 (2012): 7032–60. doi: 10.1039/C2CS35102A
   PubMed Web of Science ®Google Scholar
• L. Oehninger, R. Rubbiani, and I. Ott, “N-Heterocyclic Carbene Metal Complexes in Medicinal Chemistry,” Dalton Transactions (Cambridge, England: 2003) 42, no. 10 (2013): 3269–84. doi: 10.1039/C2DT32617E
   PubMed Web of Science ®Google Scholar
• C. S. Allardyce, and P. J. Dyson, “Ruthenium in Medicine: current Clinical Uses and Future Prospects,” Platinum Metals Review 45, no. 2 (2001): 62–9.
   Google Scholar
• D. Ompson, “e Chemistry of Precious Metals by S.A. cotton,” Gold Bulletin 31, no. 1 (1998): 35.
   Google Scholar
• B. Norden, P. Lincoln, and B. Akerman, Probing of Nucleic Acids by Metal Ion Complexes of Small Molecules. (CRC Press, Boca Raton, FL, USA, 1996), 177.
   Google Scholar
• N. W. Luedtke, J. S. Hwang, E. Nava, D. Gut, M. Kol, and Y. Tor, “e DNA and RNA Specificity of Eilatin Ru(II) Complexes as Compared to Eilatin and Ethidium Bromide,” Nucleic Acids Research 31, no. 19 (2003): 5732–40.
   PubMed Web of Science ®Google Scholar
• S. H. Sumrra, and Z. H. Chohan, “Antibacterial and Antifungal Oxovanadium(IV) Complexes of Triazole-Derived Schiff Bases,” Medicinal Chemistry Research 22, no. 8 (2013): 3934–42.
   Web of Science ®Google Scholar
• Mitat Akkoç, Sevgi Balcıoğlu, Canbolat Gürses, Tugba Taskin Tok, Burhan Ateş, and Sedat Yaşar, “Protonated Water-Soluble N-Heterocyclic Carbene Ruthenium(II) Complexes: Synthesis, Cytotoxic and DNA Binding Properties and Molecular Docking Study,” Journal of Organometallic Chemistry 869 (2018): 67–74. doi: 10.1016/j.jorganchem.2018.06.003
   Web of Science ®Google Scholar
• Khadijah M. Hindi, Tammy J. Siciliano, Semih Durmus, Matthew J. Panzner, Doug A. Medvetz, D. Venkat Reddy, Lisa A. Hogue, Christine E. Hovis, Julia K. Hilliard, Rebekah J. Mallet, et al, “Synthesis and Anticancer Properties of Gold(I) and Silver(I) N-Heterocyclic Carbenecomplexes,” Journal of Medicinal Chemistry 51, no. 6 (2008): 1577–83. doi: 10.1016/j.jorganchem.2010.10.054
   PubMedGoogle Scholar
• Siddappa Patil, James Claffey, Anthony Deally, Megan Hogan, Brendan Gleeson, Luis Miguel Menéndez Méndez, Helge Müller‐Bunz, Francesca Paradisi, and Matthias Tacke, “Synthesis, Cytotoxicity and Antibacterial Studies of p‐Methoxybenzyl‐Substituted and Benzyl‐Substituted N‐Heterocyclic Carbene-Silver Complexes,” European Journal of Inorganic Chemistry 2010, no. 7 (2010): 1020–31. doi: 10.1002/ejic.200900889
   Google Scholar
• S. Patil, A. Deally, B. Gleeson, F. Hackenberg, H. Muller-Bunz, F. Paradisi, and M. Z. Tacke. “Pd(II) and Trinuclear Ag(I) bis-N-Heterocyclic Carbene Complexes: Synthesis, Structural and in Vitro Anticancer Activity,” European Journal of Chemistry 7, no. 1 (2016): 115. doi: 10.5155/eurjchem.7.1.115-120.1387
   Google Scholar
• Siddappa Patil, Anthony Deally, Brendan Gleeson, Helge Müller-Bunz, Francesca Paradisi, and Matthias Tacke, “Novel Benzyl-Substituted N-Heterocyclic Carbene-Silver Acetate Complexes: synthesis, Cytotoxicity and Antibacterial Studies,” Metallomics: integrated Biometal Science 3, no. 1 (2011): 74–88. doi: 10.1039/c0mt00034e
   PubMed Web of Science ®Google Scholar
• Eric Assen B. Kantchev, Christopher J. O'Brien, and Michael G. Organ, “Palladium Complexes of N‐Heterocyclic Carbenes as Catalysts for Cross‐Coupling Reactions-A Synthetic Chemist’s Perspective,” Angewandte Chemie (International ed. in English) 46, no. 16 (2007): 2768–813. doi: 10.1002/anie.200601663
   PubMed Web of Science ®Google Scholar
• P. J. Barnard, M. V. Baker, S. J. Berners-Price, B. W. Skelton, and A. H. White, “Dinuclear Gold(i) Complexes of Bridging Bidentate Carbene Ligands: synthesis, Structure and Spectroscopic Characterisation,” Dalton Trans., no. 7 (2004): 1038–47. doi: 10.1039/B316804B
   PubMed Web of Science ®Google Scholar
• P. C. Kunz, C. Wetzel, S. Kogel, M. U. Kassack, and B. Spingler, “[(C3H4N2)2Au]Cl-a Bis Protic Gold(i)-NHC,” Dalton Transactions (Cambridge, England : 2003) 40, no. 1 (2011): 35–7. doi: 10.1039/C0DT01089H
   PubMed Web of Science ®Google Scholar
• P. FréMont, E. D. Stevens, M. D. Eelman, D. E. Fogg, and S. P. Nolan, “Synthesis and Characterization of Gold(I) N-Heterocyclic Carbene Complexes Bearing Biologically Compatible Moieties,” Organometallics 25, no. 24 (2006): 5824–8. doi: 10.1021/om060733d
   Web of Science ®Google Scholar
• Jennifer Weaver, Sylvain Gaillard, Caroline Toye, Stephen Macpherson, Steven P. Nolan, and Andrew Riches, “Cytotoxicity of Gold(I) N‐Heterocyclic Carbene Complexes Assessed by Using Human Tumor Cell Lines,” Chemistry (Weinheim an Der Bergstrasse, Germany) 17, no. 24 (2011): 6620–4. A. doi: 10.1002/chem.201100321
   PubMed Web of Science ®Google Scholar
• Riccardo Rubbiani, Igor Kitanovic, Hamed Alborzinia, Suzan Can, Ana Kitanovic, Liliane A. Onambele, Maria Stefanopoulou, Yvonne Geldmacher, William S. Sheldrick, Gerhard Wolber, et al, “Benzimidazol-2-Ylidene Gold(I) complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties,” Journal of Medicinal Chemistry 53, no. 24 (2010): 8608–18. doi: 10.1021/jm100801e
   PubMed Web of Science ®Google Scholar
• Divya Krishnamurthy, Mark R. Karver, Edoardo Fiorillo, Valeria Orrú, Stephanie M. Stanford, Nunzio Bottini, and Amy M. Barrios, “Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study,” Journal of Medicinal Chemistry 51, no. 15 (2008): 4790–5. doi: 10.1021/jm800101w
   PubMed Web of Science ®Google Scholar
• S. J. Berners-Price, and A. Filipovska, “Gold Compounds as Therapeutic Agents for Human Diseases,” Metallomics : integrated Biometal Science 3, no. 9 (2011): 863–73. doi: 10.1039/c1mt00062d
   PubMed Web of Science ®Google Scholar
• C.-M. Che, and R. W.-Y. Sun, “Therapeutic Applications of Gold Complexes: lipophilic Gold(III) Cations and Gold(I) complexes for anti-Cancer Treatment,” Chemical Communications (Cambridge, England) 47, no. 34 (2011): 9554–60. doi: 10.1039/C1CC10860C
   PubMed Web of Science ®Google Scholar
• B. M. Sutton, E. McGusty, D. T. Walz, and M. J. DiMartino, “Oral Gold. Antiarthritic Properties of Alkylphosphinegold Coordination Complexes,” Journal of Medicinal Chemistry 15, no. 11 (1972): 1095–8. doi: 10.1021/jm00281a001
   PubMed Web of Science ®Google Scholar
• Sabine Urig, Karin Fritz-Wolf, Régis Réau, Christel Herold-Mende, Katalin Tóth, Elisabeth Davioud-Charvet, and Katja Becker, “Undressing of Phosphine Gold(I) complexes as Irreversible Inhibitors of Human Disulfide Reductases,” Angewandte Chemie (International ed. in English) 45, no. 12 (2006): 1881–6. doi: 10.1002/anie.200502756
   PubMed Web of Science ®Google Scholar
• Riccardo Rubbiani, Suzan Can, Igor Kitanovic, Hamed Alborzinia, Maria Stefanopoulou, Malte Kokoschka, Susann Mönchgesang, William S. Sheldrick, Stefan Wölfl, and Ingo Ott, “Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) complexes of the Benzimidazolylidene Type,” Journal of Medicinal Chemistry 54, no. 24 (2011): 8646–57. doi: 10.1021/jm201220n
   PubMed Web of Science ®Google Scholar
• Wukun Liu, Kerstin Bensdorf, Maria Proetto, Adelheid Hagenbach, Ulrich Abram, and Ronald Gust, “Synthesis, Characterization, and in Vitro Studies of Bis[1,3-Diethyl-4,5- Diarylimidazol-2-Ylidene]Gold(I/III) Complexes,” Journal of Medicinal Chemistry 55, no. 8 (2012): 3713–24. doi: 10.1021/jm3000196
   PubMed Web of Science ®Google Scholar
• C. Marzano, M. Pellei, F. Tisato, and C. Santini, “Copper Complexes as Anticancer Agents,” Anti-Cancer Agents in Medicinal Chemistry 9, no. 2 (2009): 185–211. doi: 10.2174/187152009787313837
   PubMed Web of Science ®Google Scholar
• M. Barceló-Oliver, A. García-Raso, A. Terrón, E. Molins, M. J. Prieto, V. Moreno, J. Martínez, V. Lladó, I. López, A. Gutiérrez, et al. “Synthesis and Mass Spectroscopy Kinetics of a Novel Ternary Copper(II) Complex with Cytotoxic Activity against Cancer Cells,” Journal of Inorganic Biochemistry 101, no. 4 (2007): 649–59. doi: 10.1016/j.jinorgbio.2006.12.008
   PubMed Web of Science ®Google Scholar
• M. Pitié, B. Donnadieu, and B. Meunier, “Preparation of the New Bis(Phenanthroline) Ligand “Clip-Phen” and Evaluation of the Nuclease Activity of the Corresponding Copper Complex,” Inorganic Chemistry 37, no. 14 (1998): 3486–9. doi: 10.1021/ic980044x
   PubMed Web of Science ®Google Scholar
• D. Suresh, M. S. Balakrishna, K. Rathinasamy, D. Panda, and J. T. Mague, “Large-Bite Bis(Phosphite) Ligand Containing Mesocyclic Thioether Moieties: synthesis, Reactivity, Group 11 (CuI, AuI) Metal Complexes and Anticancer Activity Studies on a Human Cervical Cancer (HeLa) Cell Line,” Dalton Transactions, no. 17 (2008): 2285. doi: 10.1039/B719904J
   PubMed Web of Science ®Google Scholar
• G. M. Ehrenfeld, J. B. Shipley, D. C. Heimbrook, H. Sugiyama, E. C. Long, J. H. van Boom, G. A. van der Marel, N. J. Oppenheimer, and S. M. Hecht, “Copper-Dependent Cleavage of DNA by Bleomycin,” Biochemistry 26, no. 3 (1987): 931–42. doi: 10.1021/bi00377a038
   PubMed Web of Science ®Google Scholar
• Marie-Laure Teyssot, Anne-Sophie Jarrousse, Aurélien Chevry, Angélique De Haze, Claude Beaudoin, Michèle Manin, Steven P. Nolan, Silvia Díez-González, Laurent Morel, and Arnaud Gautier, “Toxicity of Copper(I)-NHC Complexes against Human Tumor Cells: induction of Cell Cycle Arrest, Apoptosis, and DNA Cleavage,” Chemistry (Weinheim an Der Bergstrasse, Germany) 15, no. 2 (2009): 314–8. doi: 10.1002/chem.200801992
   PubMed Web of Science ®Google Scholar
• Myriem Skander, Pascal Retailleau, Bernard Bourrié, Laurent Schio, Patrick Mailliet, and Angela Marinetti, “N-Heterocyclic Carbene-Amine Pt(II) Complexes, a New Chemical Space for the Development of Platinum-Based Anticancer Drugs,” Journal of Medicinal Chemistry 53, no. 5 (2010): 2146–54. doi: 10.1021/jm901693m
   PubMed Web of Science ®Google Scholar
• Raymond Wai-Yin Sun, Andy Lok-Fung Chow, Xiao-Hua Li, Jessie Jing Yan, Stephen Sin-Yin Chui, and Chi-Ming Che, “Luminescent Cyclometalated Platinum(ii) Complexes Containing N-Heterocyclic Carbene Ligands with Potent in Vitro and in Vivo anti-Cancer Properties Accumulate in Cytoplasmic Structures of Cancer Cells,” Chemical Science 2, no. 4 (2011): 728. doi: 10.1039/C0SC00593B
   Web of Science ®Google Scholar
• May Wantz, Mathilde Bouché, Georges Dahm, Neïla Chekkat, Sylvie Fournel, and Stéphane Bellemin-Laponnaz, “N-Heterocyclic Carbene-Polyethyleneimine (PEI) Platinum Complexes Inducing Human Cancer Cell Death: Polymer Carrier Impact,” International Journal of Molecular Sciences 19, no. 11 (2018): 3472. doi: 10.3390/ijms19113472
   PubMed Web of Science ®Google Scholar
• J. Lemke, and N. Metzler-Nolte, “Organometallic Peptide NHC Complexes of Cp∗Rh(III) and Arene Ru(II) Moieties from l-Thiazolylalanine,” Journal of Organometallic Chemistry 696, no. 5 (2011): 1018–22. doi: 10.1016/j.jorganchem.2010.12.044
   Web of Science ®Google Scholar
• P. M. Eimon, and A. L. Rubinstein, “The Use of in Vivo Zebrafish Assays in Drug Toxicity Screening,” Expert Opinion on Drug Metabolism & Toxicology 5, no. 4 (2009): 393–401. doi: 10.1517/17425250902882128
   PubMed Web of Science ®Google Scholar
• K. M. Hindi, M. J. Panzner, C. A. Tessier, C. L. Cannon, and W. J. Youngs, “The Medicinal Applications of Imidazolium Carbene-Metal Complexes,” Chemical Reviews 109, no. 8 (2009): 3859–84. doi: 10.1021/cr800500u
   PubMed Web of Science ®Google Scholar
• Lamia Boubakri, Khaireddine Dridi, Abdullah Sulaiman Al-Ayed, İsmail Özdemir, Sedat Yasar, and Naceur Hamdi, “Preparation and Characterization of PEPPSI-Palladium N-Heterocyclic Carbene Complexes Using Benzimidazolium Salts Catalyzed Suzuki-Miyaura Cross Coupling Reaction and Their Antitumor and Antimicrobial Activities,” Journal of Coordination Chemistry 72, no. 3 (2019): 516–27. doi: 10.1080/00958972.2019.1572886
   Web of Science ®Google Scholar
• N. Touj, A. Chakchouk-Mtibaa, L. Mansour, A. H. Harrath, J. Al-Tamimi, L. Mellouli, I. Özdemir, S. Yasar, and N. Hamdi, “Synthesis, Spectroscopic Properties and Biological Activity of New Cu(I) N-Heterocyclic Carbene Complexes,” Journal of Molecular Structure 1181 (2019): 209–19. doi: 10.1016/j.molstruc.2018.12.093
   Web of Science ®Google Scholar
• L. Boubakri, Abdullah S. Al-Ayed, L. Mansour, A. A. Harrath, J. Al-Tamimi, I. Özdemir, S. Yasar, N. Hamdi, et al, “In Situ Palladium/N-Heterocyclic Carbene Complex Catalyzed Carbonylative Cross-Coupling Reactions of Arylboronic Acids with 2-Bromopyridine under CO Pressure: efficient Synthesis of Unsymmetrical Arylpyridine Ketones and Their Antimicrobial Activities,” Transition Metal Chemistry 44, no. 4 (2019): 321–8. doi: 10.1007/s11243-018-00298-9
   Web of Science ®Google Scholar
• Lamia Boubakri, Abdullah S. Al-Ayed, L. Mansour, Nael Abutaha, Abdel Halim Harrath, I. Özdemir, S. Yasar, and Naceur Hamdi, “Bioactive NHC-Derived Palladium Complexes: synthesis, Catalytic Activity for the Suzuki-Miyaura Coupling of Aryl Chlorides and Bromides and Their Antibacterial Activities,” Journal of Coordination Chemistry 72, no. 16 (2019): 2688–704. doi: 10.1080/00958972.2019.1664738
   Web of Science ®Google Scholar
• Nedra Touj, Ibrahim S. Al Nasr, Waleed S. Koko, Tariq A. Khan, Ismail Özdemir, Sedat Yasar, Lamjed Mansour, Faisal Alresheedi, and Naceur Hamdi, “Anticancer, Antimicrobial and Antiparasitical Activities of Copper(I) complexes Based on N-Heterocyclic Carbene (NHC) Ligands Bearing Aryl Substituents,” Journal of Coordination Chemistry 73, no. 20-22 (2020): 2889–905. doi: 10.1080/00958972.2020.1836359
   Web of Science ®Google Scholar
• Ibrahim Al Nasr, Nedra Touj, Waleed Koko, Tariq Khan, Ismail Özdemir, Sedat Yaşar, and Naceur Hamdi, “Biological Activities of NHC-Pd(II) Complexes Based on Benzimidazolylidene N-Heterocyclic Carbene (NHC) Ligands Bearing Aryl Substituents,” Catalysts 10, no. 10 (2020): 1190. doi: 10.3390/catal10101190
   Web of Science ®Google Scholar
• Lamia Boubakri, A. Chakchouk-Mtibaa, Abdullah S. Al-Ayed, L. Mansour, Nael Abutaha, Abdel Halim Harrath, L. Mellouli, I. Özdemir, S. Yasar, Naceur Hamdi, et al, “Ru(II)-N-Heterocyclic Carbene Complexes: synthesis, Characterization, Transfer Hydrogenation Reactions and Biological Determination,” RSC Advances 9, no. 59 (2019): 34406–20. doi: 10.1039/C9RA05605J
   PubMed Web of Science ®Google Scholar
• Matthew N. Hopkinson, Christian Richter, Michael Schedler, and Frank Glorius, “An Overview of N-Heterocyclic Carbenes,” Nature 510, no. 7506 (2014): 485–96. doi: 10.1038/nature13384
   PubMed Web of Science ®Google Scholar
• James L. Hickey, Rasha A. Ruhayel, Peter J. Barnard, Murray V. Baker, Susan J. Berners-Price, and Aleksandra Filipovska, “Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I) N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols,” Journal of the American Chemical Society 130, no. 38 (2008): 12570–1. doi: 10.1021/ja804027j
   PubMed Web of Science ®Google Scholar
• Luciano Oehninger, Maria Stefanopoulou, Hamed Alborzinia, Julia Schur, Stephanie Ludewig, Kazuhiko Namikawa, Alvaro Muñoz-Castro, Reinhard W. Köster, Knut Baumann, Stefan Wölfl, et al, “Evaluation of Arene Ruthenium (II) N-Heterocyclic Carbene Complexes as Organometallics Interacting with Thiol and Selenol Containing Biomolecules,” Dalton Transactions (Cambridge, England : 2003) 42, no. 5 (2013): 1657–66. doi: 10.1039/C2DT32319B
   PubMed Web of Science ®Google Scholar
• I. Ott, and R. Gust, “Non Platinum Metal Complexes as anti-Cancer Drugs,” Archiv Der Pharmazie 340, no. 3 (2007): 117–26. doi: 10.1002/ardp.200600151
   PubMed Web of Science ®Google Scholar
• A. Bergamo, and G. Sava, “Ruthenium Anticancer Compounds: myths and Realities of the Emerging Metal-Based Drugs,” Dalton Transactions (Cambridge, England : 2003) 40, no. 31 (2011): 7817–23. doi: 10.1039/C0DT01816C
   PubMed Web of Science ®Google Scholar
• O. Çiftci, A. Beytur, N. Vardi, and İ. Özdemir, “Evaluation of Reproductive Toxicity in Male Rats Treated with Novel Synthesized Ruthenium(II) and Gold(I)-NHC Complexes,” Drug Development and Industrial Pharmacy 38, no. 1 (2012): 40–6. doi: 10.3109/03639045.2011.589853
   PubMed Web of Science ®Google Scholar
• M. A. Jakupec, M. Galanski, W. B. Arion, C. G. Hartinger, and B. K. Keppler, “Antitumour Metal Compounds: more than Theme and Variations,” Dalton Transactions 0, no. 2 (2008): 183–94. doi: 10.1039/B712656P
   Google Scholar
• K. Guven, E. Yucel, and F. Cetintas, “Antimicrobial Activities of Fruits of Crataegus. and Pyrus,” Species, Pharmaceutical Biology 44, no. 2 (2006): 79–83.
   Web of Science ®Google Scholar
• I. Sellem, K. Kaaniche, A. Chakchouk-Mtibaa, and L. Mellouli, “Anti-Oxidant, Antimicrobial and anti-Acetylcholinesterase Activities of Organic Extracts from Aerial Parts of Three Tunisian Plants and Correlation with Polyphenols and Flavonoids Contents,” Bangladesh Journal of Pharmacology 11, no. 2 (2016): 531–44.
   Web of Science ®Google Scholar
• G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Feather-Stone, “A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity,” Biochemical Pharmacology 7 (1961): 88–95.
   PubMed Web of Science ®Google Scholar
• N. Rangkadilok, S. Sitthimonchai, L. Worasuttayangkurn, C. Mahidol, M. Ruchirawat, and J. Satayavivad, “Evaluation of Free Radical Scavenging and Antityrosinase Activities of Standardized Longan Fruit Extract,” Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 45, no. 2 (2007): 328–36.
   PubMed Web of Science ®Google Scholar
• A. J. Kirby, and R. J. Schmidt, “The Antioxidant Activity of Chinese Herbs for Eczema and of Placebo Herbs — I,” Journal of Ethnopharmacology 56, no. 2 (1997): 103–8.
   PubMed Web of Science ®Google Scholar
• R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay,” Free Radical Biology & Medicine 26, no. 9-10 (1999): 1231–7.
   PubMed Web of Science ®Google Scholar
• D. E. Pratt, “Natural Antioxidants of Soybeans and Other Oil-Seeds,” Autoxidation in Food and Biological Systems (1980): 283–93.
   Google Scholar
• Boubakri Lamia, Ahlem Chakchouk-Mtibaa, Bilel Hallouma, Lamjed Mansour, Lotfi Mellouli, Ismail Özdemir, Sedat Yaşar, and Naceur Hamdi, “A Palladium Catalyst System for the Efficient Cross-Coupling Reaction of Aryl Bromides and Chlorides with Phenylboronic Acid: Synthesis and Biological Activity Evaluation,” Molecules 22, no. 3 (2017): 420. doi: 10.3390/molecules22030420.
   PubMed Web of Science ®Google Scholar
• Murat Kaloğlu, Ichraf Slimani, Namık Özdemir, Nevin Gürbüz, Naceur Hamdi, and İsmail Özdemir, “The Direct C(sp2)-H Functionalization and Coupling of Aromatic N-Heterocycles with (Hetero)Aryl Bromides by [PdX2(Imidazolidin-2-Ylidene)(Py)] Catalysts,” Journal of Organometallic Chemistry 951 (2021): 122013.
   Web of Science ®Google Scholar
• Ichraf Slimani, Lamjed Mansour, Ismail Özdemir, Nevin Gürbüz, and Naceur Hamdi, “Synthesis, Characterization and Catalytic Activity of PEPPSI-Type Palladium–NHC Complexes,” Inorganica Chimica Acta 515 (2021): 120043.
   Web of Science ®Google Scholar
• Ichraf Slimani, Lamjed Mansour, Nael Abutaha, Abdel Halim Harrath, Jameel Al-Tamimi, Nevin Gürbüz, I. Özdemir, and Naceur Hamdi, “Synthesis, Structural Characterization of Silver(I)-NHC Complexes and Their Antimicrobial, Antioxidant and Antitumor Activities,” Journal of King Saud University - Science 32, no. 2 (2020): 1544–54.
   Web of Science ®Google Scholar
• (a) D. Mishra, A. Mishra, V. K. Chaturvedi, and M. P. Singh, “An Overview of COVID-19 with an Emphasis on Computational Approach for Its Preventive Intervention,” 3 Biotech 10, no. 10 (2020): 435. ;
   PubMedGoogle Scholar
  (b) Lamia Boubakri, Ahlem Chakchouk-Mtiba, Olfa Naouali, Lotfi Mellouli, Lamjed Mansour, Ismail Özdemir, Sedat Yaser, Mathieu Sauthier, and Naceur Hamdi, “Ruthenium(II) Complexes Bearing Benzimidazole-Based N-Heterocyclic Carbene (NHC) Ligands as Potential Antimicrobial, Antioxidant, Enzyme Inhibition, and Antiproliferative Agents,” Journal of Coordination Chemistry 75, no. 5-6 (2022): 645–67. 2022
   Web of Science ®Google Scholar
• C. N. Ciurea, I. B. Kosovski, A. D. Mare, F. Toma, I. A. Pintea-Simon, and A. Man, “Candida and Candidiasis—Opportunism versus Pathogenicity: A Review of the Virulence Traits,” Microorganisms 8, no. 6 (2020): 857–74.
   PubMed Web of Science ®Google Scholar
• M. G. Lionetto, R. Caricato, A. Calisi, M. E. Giordano, and T. Schettino, “Acetylcholinesterase as a Biomarker in Environmental and Occupational Medicine: New Insights and Future Perspectives,” BioMed Research International 2013 (2013): 1–8.
   Web of Science ®Google Scholar
• Sarfraz Ahmad Nawaz, and Iqbal M. Choudhary, Atia-Tul-Wahab , “New Cholinesterase Inhibiting Bisbenzylisoquinoline Alkaloids from Cocculus Pendulus,” Chemical & Pharmaceutical Bulletin 52, no. 7 (2004): 802–6.
   PubMed Web of Science ®Google Scholar
• W. Ahmad, B. Ahmad, M. Ahmad, Z. Iqbal, M. Nisar, and M. Ahmad, “In vitro Inhibition of Acetylcholinesterase, Butyrylxcholinesterase and Lipoxygenase by Crude Extract of Myricaria elegans Royle,” Journal of Biological Science 3 (2003): 1046–9.
   Google Scholar
• S. Zolghadri, A. Bahrami, M. T. H. Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas, and A. A. Saboury, “A Comprehensive Review on Tyrosinase Inhibitors,” Journal of Enzyme Inhibition and Medicinal Chemistry 34, no. 1 (2019): 279–309.
   PubMed Web of Science ®Google Scholar
• V. M. Dembitsky, and A. Kilimnik, and M. J. Pharma,“Anti-Melanoma Agents Derived from Fungal Species,” Malaysian Journal of Pharmacy, no. 1 (2016): 1–16.
   Google Scholar
• H. A. Bay, B. Quaddouri, A. Guaadaoui, R. Touzani, N.-E. Benchat, A. Hamal, M. Taleb, M. Bellaoui, and S. E. Kadiri, “Synthesis and Biological Activity of New Triazole Compounds,” Letters in Drug Design & Discovery 7, no. 1 (2010): 41–5. doi: 10.2174/157018010789869352
   Web of Science ®Google Scholar
• S. Y. Lee, C. Y. Kim, and T.-G. Nam, “Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives,” Drug Design, Development and Therapy 14 (2020): 5375–92.
   PubMed Web of Science ®Google Scholar
• I. Kostova, “Ruthenium Complexes as Anticancer Agents,” Current Medicinal Chemistry 13, no. 9 (2006): 1085–107.
   PubMed Web of Science ®Google Scholar
• S. J. Dougan, A. Habtemariam, S. E. McHale, S. Parsons, and P. J. Sadler, “Catalytic Organometallic Anticancer Complexes,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 33 (2008): 11628–33.
   PubMed Web of Science ®Google Scholar
• W. Kandioller, E. Balsano, S. M. Meier, U. Jungwirth, S. Göschl, A. Roller, M. A. Jakupec, W. Berger, B. K. Keppler, and C. G. Hartinger, “Organometallic Anticancer Complexes of Lapachol: Metal Centre-Dependent Formation of Reactive Oxygen Species and Correlation with Cytotoxicity,” Chemical Communications (Cambridge, England) 49, no. 32 (2013): 3348–50.
   PubMed Web of Science ®Google Scholar
• P. Zhang, and P. J. Sadler, “Advances in the Design of Organometallic Anticancer Complexes,” Journal of Organometallic Chemistry. 839 (2017): 5–14.
   Web of Science ®Google Scholar
• V. R. Silva, R. S. Corrêa, L. D. S. Santos, M. B. P. Soares, A. A. Batista, and D. P. Bezerra, “A Ruthenium-Based 5-Fluorouracil Complex with Enhanced Cytotoxicity and Apoptosis Induction Action in HCT116 Cells,” Scientific Reports 8, no. 1 (2018): 288.
   PubMedGoogle Scholar
• J. Shum, P. K.-K. Leung, and K. K.-W. Lo, “Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications,” Inorganic Chemistry 58, no. 4 (2019): 2231–47.
   PubMed Web of Science ®Google Scholar
• C.-P. Tan, Y.-M. Zhong, L.-N. Ji, and Z.-W. Mao, “Phosphorescent Metal Complexes as Theranostic Anticancer Agents: Combining Imaging and Therapy in a Single Molecule,” Chemical Science 12, no. 7 (2021): 2357–67.
   PubMed Web of Science ®Google Scholar
• M. Xu, Y. Wen, Y. Liu, X. Tan, X. Chen, X. Zhu, C. Wei, L. Chen, Z. Wang, and J. Liu, “Hollow Mesoporous Ruthenium Nanoparticles Conjugated Bispecific Antibody for Targeted anti-Colorectal Cancer Response of Combination Therapy,” Nanoscale 11, no. 19 (2019): 9661–78.
   PubMed Web of Science ®Google Scholar
• X. Zhu, Y. Gong, Y. Liu, C. Yang, S. Wu, G. Yuan, X. Guo, J. Liu, and X. Qin, “Ru@CeO2 Yolk Shell Nanozymes: Oxygen Supply in Situ Enhanced Dual Chemotherapy Combined with Photothermal Therapy for Orthotopic/Subcutaneous Colorectal Cancer,” Biomaterials 242 (2020): 119923.
   PubMed Web of Science ®Google Scholar
• Aylin Yilmaz, Richard W. Price, and Magnus Gisslén, “Antiretroviral Drug Treatment of CNS HIV-1 Infection,” The Journal of Antimicrobial Chemotherapy 67, no. 2 (2012): 299–311.
   PubMed Web of Science ®Google Scholar
• S. Zolghadri, A. Bahrami, M. T. H. Mahmud Tareq Hassan Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas, and A. A. Saboury, “A Comprehensive Review on Tyrosinase Inhibitors,” Journal of Enzyme Inhibition and Medicinal Chemistry 34, no. 1 (2019): 279–309. doi: 10.1080/14756366.2018.1545767
   PubMed Web of Science ®Google Scholar
• A. Yilmaz, R. W. Price, and M. Gissle, “Antiretroviral Drug Treatment of CNS HIV-1 Infection,” The Journal of Antimicrobial Chemotherapy 67, no. 2 (2012): 299–311. doi: 10.1093/jac/dkr492.
   PubMed Web of Science ®Google Scholar
• T. Mosmann, “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods 65, no. 1-2 (1983): 55–63.
   PubMed Web of Science ®Google Scholar
• V. Gangadevi, and J. Muthumary, “Preliminary Studies on Cytotoxic Effect of Fungal Taxol on Cancer Cell Lines,” Journal of Immunological Methods 6 (2007): 1382–6.
   Google Scholar
• M. Harison, J. Wang, and I. J. B. Lin, “Facile Synthesis of Silver(I)−Carbene Complexes. Useful Carbene Transfer Agents,” Organometallics 17, no. 5 (1998): 972–5. doi: 10.1021/om9709704
   Web of Science ®Google Scholar